Inpatient Workup for Confusion in a Chemotherapy Patient
The workup for acute confusion in a chemotherapy patient must systematically identify reversible metabolic and treatment-related causes through targeted laboratory testing, medication review, and selective neuroimaging, as these patients face unique cancer-specific and chemotherapy-induced etiologies beyond typical delirium causes.
Initial Laboratory Assessment
The cornerstone of evaluation involves comprehensive metabolic testing to identify reversible causes 1:
Essential Laboratory Tests
- Serum calcium - Hypercalcemia is a critical reversible cause in cancer patients, particularly those with bone metastases
- Serum sodium and osmolality - SIADH is common with small cell lung cancer and platinum-based chemotherapy, vinca alkaloids, and opioids 1
- Serum magnesium - Hypomagnesaemia occurs with cisplatin and cetuximab and can cause confusion, hallucinations, and seizures 1
- Complete metabolic panel - Including renal function, liver function, and glucose
- Complete blood count - To assess for infection or cytopenias
Critical Diagnostic Considerations
For suspected SIADH: Confirm with inappropriately high urine osmolality and reduced serum osmolality in a clinically euvolemic patient, but exclude adrenal insufficiency first 1.
For hypomagnesaemia: Monitor levels closely as replacement with IV magnesium sulfate may reverse neurological symptoms including confusion 1.
Medication Review
Immediately review and consider withdrawing offending chemotherapy agents, particularly those crossing the blood-brain barrier such as capecitabine, topotecan, or ifosfamide 1. Most chemotherapy-induced delirium episodes are idiosyncratic and reverse after medication withdrawal 1.
Also evaluate:
- Opioids
- Benzodiazepines
- Corticosteroids
- Antipsychotics
- NSAIDs
- Anticonvulsants
- Antidepressants
- Novel immunotherapies (which cause cytokine-mediated confusion) 1
Neuroimaging Strategy
CT head is usually appropriate for patients presenting with delirium 2, though yield may be low without trauma or focal neurological deficits.
Indications for Neuroimaging (CT or MRI):
- High clinical suspicion for acute neurological cause
- Focal neurological deficits present
- History of falls or trauma
- Symptoms not responding to initial management
- No clear cause identified on initial assessment 2
MRI with diffusion-weighted imaging should be obtained if chemotherapy-induced leukoencephalopathy is suspected, particularly in patients on 5-fluorouracil presenting with seizures and altered mental status, as this shows characteristic symmetric white matter lesions in parietal and occipital lobes 3.
Additional Workup Based on Clinical Context
- Infectious evaluation - Blood cultures, urinalysis, chest imaging if infection suspected
- Cardiac evaluation - ECG and troponins if embolic phenomena or cardiac complications suspected 4
- Imaging for metastases - Brain MRI if CNS metastases not previously ruled out
Common Pitfalls to Avoid
Missing multiple simultaneous causes - 69% of confused cancer patients have multiple contributing factors (median of 3) rather than a single cause 1
Overlooking bone metastases as a risk factor - These independently predict delirium even with normal calcium levels 1
Rapid correction of severe hyponatremia - Risk of osmotic demyelination syndrome requires close monitoring 1
Assuming non-neurologic cause excludes need for imaging - There is disagreement in guidelines about imaging when a suspected non-neurologic cause is found; maintain low threshold for neuroimaging 2
Forgetting cancer-specific causes - Including paraneoplastic syndromes, hyperviscosity in hematologic malignancies, and non-bacterial thrombotic endocarditis 4